SCHEMBL1384565

SCHEMBL1384565

O=C1CN(S(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)CCN1Cc1cc2cnccc2[nH]1

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.71
F2 P00734 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387431 0.84 F10 (0.69) F10F2
SCHEMBL1652907 0.84 F10 (0.61) F10F2
SCHEMBL1384898 0.83 F10 (1.00) F10F2
SCHEMBL27526711 0.81 F10 (0.73) F10F2
SCHEMBL1653245 0.80 F10 (1.00) F10F2
SCHEMBL1653247 0.80 F10 (1.00) F10F2
SCHEMBL1386994 0.80 KCNH2 (0.48) F10F2
SCHEMBL4389027 0.79 F10 (1.00) F10F2
SCHEMBL1652792 0.79 F10 (0.55) F10F2
SCHEMBL4390820 0.78 F10 (1.00) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed